Last edition
News about "Valo Health "
Merck KGaA Inks Up to USD 3 Billion AI-Driven Drug Discovery Deal with Valo Health
Merck KGaA has entered into a major strategic collaboration with Valo Health to use Valo’s AI-powered human causal biology platform for discovering and developing new treatments for Parkinson’s disease and related disorders.
Valo Health | 21/11/2025 | By Darshana | 213
Valo Health and Novo Nordisk to Develop Novel Treatments for Cardiometabolic Diseases
The expanded collaboration will continue to leverage the capabilities of Valo’s Opal Computational Platform, as well as key joint capabilities in human data and genetics with Novo Nordisk’s expertise in cardiometabolic diseases.
Valo Health | 09/01/2025 | By Aishwarya | 436
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy